Verona Pharma (NASDAQ:VRNA – Free Report) had its price objective cut by HC Wainwright from $33.00 to $30.00 in a research note published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Verona Pharma’s FY2024 earnings at ($1.36) EPS, Q1 2025 earnings at ($0.24) […]
Royalty Pharma plc (NASDAQ:RPRX) Receives $46 75 Average Target Price from Analysts etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Hookipa Pharma (NASDAQ:HOOK) Releases Earnings Results dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.75 and traded as high as $3.08. Acasti Pharma shares last traded at $2.96, with a volume of 13,180 shares trading hands. Analyst Ratings Changes Separately, Craig […]
Valeo Pharma (TSE:VPH) Stock Price Down 14 3% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.